Fei Xiao
0000-0003-2054-901X
Publication & Citation Trends
Publications
0 total
Early serial circulating tumor DNA sequencing predicts the efficacy of chemohormonal therapy in patients with metastatic hormone-sensitive prostate cancer OA
Cited by 7
Semantic Scholar
Engineering the MoS2/MXene Heterostructure for Precise and Noninvasive Diagnosis of Prostate Cancer with Clinical Specimens OA
Cited by 21
Semantic Scholar
Early Plasma Circulating Tumor DNA as a Potential Biomarker of Disease Recurrence in Non-metastatic Prostate Cancer OA
Cited by 14
Semantic Scholar
The prognostic nomogram including MRI for locally advanced prostate cancer treated by radical prostatectomy
Cited by 3
Semantic Scholar
The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study OA
Cited by 4
Semantic Scholar
Targeted Next-Generation Sequencing Reveals Heterogenous Genomic Features in Viscerally Metastatic Prostate Cancer
Cited by 5
Semantic Scholar
Clinical and molecular features of Epstein‐Barr virus‐positive diffuse large B‐cell lymphoma: Results in a multi‐center trial OA
Cited by 9
Semantic Scholar
Distinct Response to Platinum-Based Chemotherapy among Patients with Metastatic Castration-Resistant Prostate Cancer Harboring Alterations in Genes Involved in Homologous Recombination
Cited by 16
Semantic Scholar
A cohort autopsy study defines COVID-19 systemic pathogenesis OA
Cited by 128
Semantic Scholar
Research Topics
Lung Cancer Diagnosis and Treatment
(25)
RNA modifications and cancer
(24)
RNA Research and Splicing
(17)
Chronic Obstructive Pulmonary Disease (COPD) Research
(14)
Lung Cancer Treatments and Mutations
(11)
Affiliations
Shihezi University
Hubei University of Medicine
The University of Texas MD Anderson Cancer Center
Nanjing University of Finance and Economics
Nanchang University